Darmerica

Darmerica is a Florida-based wholesale distributor and supplier specializing in active pharmaceutical ingredients (APIs), peptides, and nutraceuticals. Established in 2016, the company serves as a premier supplier for compounding pharmacies, R&D laboratories, and the broader healthcare industry. Its product portfolio includes small molecules, herbal extracts, and anti-aging materials, with a significant focus on metabolic and weight-loss related peptides such as GLP-1 receptor agonists. Darmerica operates from FDA-inspected and cGMP-compliant facilities, providing custom sourcing, repackaging, and technical support services. In late 2025, the company received regulatory attention for its distribution of experimental peptides like retatrutide, highlighting its prominent role in the pharmaceutical supply chain.